Daiwa Securities Group
SCMP

Daiwa Securities Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Daiwa Securities Group’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-463,114
Closed -$7.61M – 1012
2015
Q2 		$7.61M Buy
+463,114
New +$8.03M 0.05% 138

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Daiwa Securities Group's SCMP Position: Q3 2015 in Review

Daiwa Securities Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2015, closing a stake of 463,114 shares — an estimated $7.61M sold.

Daiwa Securities Group first reported a position in SCMP in Q2 2015 and held it in 1 quarter. The position peaked at $7.61M in Q2 2015. 154 funds tracked by Wall St. Rank hold SCMP as of Q3 2015.

  • Daiwa Securities Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Daiwa Securities Group sold 463,114 Sucampo Pharmaceuticals, Inc. shares in Q3 2015, an estimated $7.61M.
  • Daiwa Securities Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and held it in 1 quarter.
  • Daiwa Securities Group's Sucampo Pharmaceuticals, Inc. position peaked at $7.61M in Q2 2015.
  • 154 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2015.

Based on Daiwa Securities Group's 13F filing for Q3 2015, filed 10 Nov 2015.